Episode 54
Biotech Hangout
00:00
The Mixed Panel Vote on NFL and Lekenbe
The CNS division had a mixed panel vote, I call it mixed. And so our takeaway unless you guys have a different view is like yes, an accelerated approval is possible. That will also then lead us to perhaps an unsurprising but expected panel for Lekenbe and Lekenemab which we were told there is going to be a panel for that for Alzheimer's to get the full approval. So maybe I'll turn it over to Josh if he wants to talk about NFL and his thoughts around that and then Gene Therapy.
Transcript
Play full episode
